NCI

Use of complementary and alternative medicine differs by race and socioeconomic factors, study reports.

Vanderbilt investigators have identified how two key components of cancer's invasive "switch" — the series of signaling events that turn on a tumor cell’s invasive behavior — work together.

“Orphan” enzyme may play role in cancer growth, new research suggests.

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.

The respiratory virus HMPV uses its fusion (F) protein – which interacts with cellular receptors called integrins – to bind to and enter target cells.

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.

Dysfunction or loss of an “antioxidant” enzyme may lead to higher risk for esophageal cancer in patients with gastric reflux disease.